STOCK TITAN

Ginkgo Bioworks Holdings Stock Price, News & Analysis

DNABW OTC Link

Company Description

Ginkgo Bioworks Holdings (OTC Link: DNABW) is a publicly traded company.

DNABW stock has declined 80.0% over the past year. Shares last traded at $0.0020.

On a trailing twelve-month basis, Ginkgo Bioworks Holdings reported revenue of $170.2M with net income of -$312.8M and diluted earnings per share of $-5.64. The company operates at a net profit margin of -183.8%.

This page provides a comprehensive overview of DNABW stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.

Stock Performance

$—
0.00%
0.00
Last updated:
-80%
Performance 1 year

Ginkgo Bioworks Holdings (DNABW) stock last traded at $0.0020. Over the past 12 months, the stock has lost 80.0%.

Latest News

No recent news available for DNABW.

SEC Filings

Ginkgo Bioworks Holdings has filed 5 recent SEC filings, including 2 Form 144, 1 Form SCHEDULE 13G/A, 1 Form 10-K, 1 Form 8-K. The most recent filing was submitted on March 26, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all DNABW SEC filings →

Financial Highlights

Ginkgo Bioworks Holdings generated $170.2M in revenue over the trailing twelve months, operating income reached -$315.3M (-185.3% operating margin), and net income was -$312.8M, reflecting a -183.8% net profit margin. Diluted earnings per share stood at $-5.64. The company generated -$171.1M in operating cash flow. With a current ratio of 4.92, the balance sheet reflects a strong liquidity position.

$170.2M
Revenue (TTM)
-$312.8M
Net Income (TTM)
-$171.1M
Operating Cash Flow

Upcoming Events

Short Interest History

Last 12 Months

Short interest in Ginkgo Bioworks Holdings (DNABW) currently stands at 10.9 thousand shares. Over the past 12 months, short interest has decreased by 72.6%.

Days to Cover History

Last 12 Months

Days to cover for Ginkgo Bioworks Holdings (DNABW) currently stands at 1.0 days. This low days-to-cover ratio indicates high liquidity, allowing short sellers to quickly exit positions if needed. The ratio has shown significant volatility over the period, ranging from 1.0 to 4.1 days.

Frequently Asked Questions

What is the current stock price of Ginkgo Bioworks Holdings (DNABW)?

The current stock price of Ginkgo Bioworks Holdings (DNABW) is $0.002 as of April 2, 2026.

What is the revenue (TTM) of Ginkgo Bioworks Holdings (DNABW) stock?

The trailing twelve months (TTM) revenue of Ginkgo Bioworks Holdings (DNABW) is $170.2M.

What is the net income of Ginkgo Bioworks Holdings (DNABW)?

The trailing twelve months (TTM) net income of Ginkgo Bioworks Holdings (DNABW) is -$312.8M.

What is the earnings per share (EPS) of Ginkgo Bioworks Holdings (DNABW)?

The diluted earnings per share (EPS) of Ginkgo Bioworks Holdings (DNABW) is $-5.64 on a trailing twelve months (TTM) basis. Learn more about EPS .

What is the operating cash flow of Ginkgo Bioworks Holdings (DNABW)?

The operating cash flow of Ginkgo Bioworks Holdings (DNABW) is -$171.1M. Learn about cash flow.

What is the profit margin of Ginkgo Bioworks Holdings (DNABW)?

The net profit margin of Ginkgo Bioworks Holdings (DNABW) is -183.8%. Learn about profit margins.

What is the operating margin of Ginkgo Bioworks Holdings (DNABW)?

The operating profit margin of Ginkgo Bioworks Holdings (DNABW) is -185.3%. Learn about operating margins.

What is the current ratio of Ginkgo Bioworks Holdings (DNABW)?

The current ratio of Ginkgo Bioworks Holdings (DNABW) is 4.92, indicating the company's ability to pay short-term obligations. Learn about liquidity ratios.

What is the operating income of Ginkgo Bioworks Holdings (DNABW)?

The operating income of Ginkgo Bioworks Holdings (DNABW) is -$315.3M. Learn about operating income.